Reck, M., Ciuleanu, T., Lee, J., Schenker, M., Zurawski, B., Kim, S., . . . Brahmer, J. R. (2023). Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
Citação norma ChicagoReck, Martin, et al. Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1. 2023.
Citação norma MLAReck, Martin, et al. Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1. 2023.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.